During the mean observation period of 3.3 years, semaglutide at 2.4 mg per week resulted in a mean weight loss of 9.39% from baseline and a 20% reduction in the risk of MACE (HR 0.80, 95% CI 0.720.90), especially a 28% reduction in the risk of myocardial infarction (HR 0.72, 95% CI 0.610.85), compared with that in the placebo group
No specific antidote is available for the treatment of Glutathione overdosage
Continuous Subcutaneous Glucose Monitoring System in diabetic mothers during labour and postnatal glucose adaptationof their infants
Bhargava, J
All participants also received lifestyle counselling as part of the study protocol, which is consistent with standard clinical practice in obesity management
HCV presents high mutation rates and because of that it has been evolved to different genotypes based on nucleotide sequence heterogeneity and classified in six major genotypes and more than 50 subtypes.9 Molecular epidemiologic studies reveal that HCV genotypes coexist in various geographic locations with different prevalence.9 Several reports have shown prevalence of genotypes 1, 2, 3, 4 and 5 in Latin America.10-12 In Mexico the predominant genotype is 1 (72.2%), followed by genotype 2 (18%) and 3 (9.8%).6 Unfortunately, in Northeast of Mexico, which includes States that are located in the border with USA, there is a little information about frequency of HCV genotypes, and clinical and demographic data in patients infected with HCV.13 In this study we report the distribution of HCV genotypes and the principal risk factors in HCV infected patients from Northeast of Mexico
